Item 8.01. Other Events.
The Board of Directors (the "Board") of Cara Therapeutics, Inc. (the "Company")
adopted the Cara Therapeutics, Inc. 2019 Inducement Plan (the "Inducement
Plan"), effective as of November 20, 2019. The Company reserved 300,000 shares
of the Company's common stock for issuance under the Inducement Plan. The only
persons eligible to receive grants of Awards (as defined below) under the
Inducement Plan are individuals who satisfy the standards for inducement grants
in accordance with the Nasdaq Stock Market LLC listing rules, including
individuals who were not previously an employee or director of the Company, or
following a bona fide period of non-employment, as an inducement material to
such persons entering into employment with the Company. An "Award" is any right
to receive the Company's common stock pursuant to the Inducement Plan,
consisting of nonstatutory stock options, restricted stock awards, restricted
stock unit awards or other stock-based awards. The Board also adopted a form of
option grant notice and stock option agreement and form of restricted stock unit
grant notice and restricted stock agreement (the "Related Agreements") for use
with the Inducement Plan.
The foregoing description of the Inducement Plan and Related Agreements is not
complete and is qualified in its entirety by reference to the text of the
Inducement Plan and Related Agreements, which are filed as Exhibits 10.1, 10.2
and 10.3, respectively, to this Current Report on Form 8-K.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits
Exhibit No. Description
10.1 Cara Therapeutics, Inc. 2019 Inducement Plan
10.2 Form of Stock Option Grant Notice and Stock Option Agreement under
Cara Therapeutics, Inc. 2019 Inducement Plan
10.3 Form of Restricted Stock Unit Grant Notice and Restricted Stock
Unit Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
CARA THERAPEUTICS, INC. 
